Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

590
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
590
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

925
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
925
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

494
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
494
Relative Risk01:12

Relative Risk

1.6K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transcriptomic profiling of an in vivo diffuse large B-cell lymphoma model reveals molecular programs underlying CNS dissemination.

Annals of hematology·2026
Same author

Response kinetics as a dynamic prognostic marker in patients with multiple myeloma.

Leukemia·2026
Same author

Anbalcabtagene autoleucel (PD-1 and TIGIT knockdown CD19 CAR-T) for relapsed/refractory large B-cell lymphoma (CRC01-01).

Blood·2026
Same author

The prognostic factors and immune microenvironment of primary plasma cell leukemia: the KMMWP-2204 study.

Haematologica·2026
Same author

Glofitamab plus gemcitabine and oxaliplatin for relapsed/refractory DLBCL: 3-year follow-up of STARGLO.

Blood advances·2026
Same author

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry.

Blood cancer journal·2026
Same journal

Association between HPV-16 and HPV-18 viral loads and severity of cervical pre-invasive lesions in women with and without HIV in Botswana.

Frontiers in oncology·2026
Same journal

Radiomics-based interpretable machine learning model from multiphasic CT imaging for predicting pathological grade in upper tract urothelial carcinoma: a multicenter study.

Frontiers in oncology·2026
Same journal

Case Report: Conversion therapy for initially unresectable intrahepatic cholangiocarcinoma.

Frontiers in oncology·2026
Same journal

Analysis of ultrasonic characteristics in 12 cases of ovarian Sertoli-Leydig cell tumour.

Frontiers in oncology·2026
Same journal

Severe asparaginase-associated hypertriglyceridemia in pediatric acute lymphoblastic leukemia: a single-center experience.

Frontiers in oncology·2026
Same journal

Evaluation of the CIB1R peptide derived from the cytoplasmic domain of neprilysin on cell migration in an <i>in vitro</i> model of lung cancer.

Frontiers in oncology·2026
See all related articles

Related Experiment Video

Updated: Dec 25, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K

Risk Stratification Using Multivariable Fractional Polynomials in Diffuse Large B-Cell Lymphoma.

Jin Roh1, Jiwon Jung2,3, Yourim Lee4

  • 1Department of Pathology, Ajou University School of Medicine, Suwon, South Korea.

Frontiers in Oncology
|March 29, 2020
PubMed
Summary
This summary is machine-generated.

A new prognostic model for diffuse large B-cell lymphoma (DLBCL) improves risk stratification. This model incorporates key factors like age and BCL2 expression, offering a more precise assessment than traditional methods for better patient management.

Keywords:
diffuse large B-cell lymphomamultivariable fractional polynomialprognosisprognostic modelrisk stratification

More Related Videos

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

433
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

581

Related Experiment Videos

Last Updated: Dec 25, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

433
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

581

Area of Science:

  • Oncology
  • Hematology
  • Biostatistics

Background:

  • Accurate risk stratification is vital for managing diffuse large B-cell lymphoma (DLBCL).
  • The International Prognostic Index (IPI) is a traditional system but has limitations due to fixed, dichotomized attributes.
  • There is a need for a more comprehensive and flexible prognostic model for DLBCL.

Purpose of the Study:

  • To develop and validate a novel prognostic model for primary DLBCL.
  • To incorporate up-to-date clinicopathologic attributes comprehensively without information loss.
  • To improve upon the limitations of the traditional International Prognostic Index.

Main Methods:

  • Analysis of 204 primary DLBCL patients uniformly treated with R-CHOP from 2007-2012.
  • Application of the multivariable fractional polynomial (MFP) method and bootstrap resampling for variable selection and functional form determination.
  • Identification of significant predictors for overall survival (OS) and event-free survival (EFS).

Main Results:

  • Age, serum β2-microglobulin, serum lactate dehydrogenase, and BCL2 expression were significant predictors of OS.
  • Age was excluded as a predictor for 2-year event-free survival.
  • The MFP model effectively stratified patients into four risk groups with distinct 5-year OS rates (89.91% low risk to 37.89% high risk).

Conclusions:

  • A new, simple, and flexible prognostic model for DLBCL risk stratification was developed using the MFP method.
  • This model allows comprehensive incorporation of clinicopathologic factors without arbitrary dichotomization, enhancing prognostic accuracy.
  • The proposed model offers improved risk classification for DLBCL patients treated with R-CHOP therapy.